ATE203907T1 - Dermatologische zubereitung zur behandlung von aktinischen keratosen - Google Patents

Dermatologische zubereitung zur behandlung von aktinischen keratosen

Info

Publication number: ATE203907T1
Authority: AT; Austria
Prior art keywords: treatment; actinic keratosis; dermatological preparation; composition; dermatological
Prior art date: 1995-04-12

Application number

AT96912861T

Other languages

English (en)

Inventor

Bruce E Katz

Original Assignee

Bruce E Katz

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-04-12

Filing date

1996-04-10

Publication date

2001-08-15

1996-04-10 Application filed by Bruce E Katz filed Critical Bruce E Katz

2001-08-15 Application granted granted Critical

2001-08-15 Publication of ATE203907T1 publication Critical patent/ATE203907T1/de

Links

208000009621 actinic keratosis Diseases 0.000 title abstract 2
GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 abstract 1
BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 abstract 1
229960002949 fluorouracil Drugs 0.000 abstract 1
239000004615 ingredient Substances 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Cosmetics (AREA)
Medicines Containing Plant Substances (AREA)

AT96912861T 1995-04-12 1996-04-10 Dermatologische zubereitung zur behandlung von aktinischen keratosen ATE203907T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/421,674 US5627187A (en)	1995-04-12	1995-04-12	5-FU for treating actinic kerotoses
PCT/US1996/005346 WO1996032112A1 (en)	1995-04-12	1996-04-10	Dermatological preparation and method for treating actinic keratoses

Publications (1)

Publication Number	Publication Date
ATE203907T1 true ATE203907T1 (de)	2001-08-15

Family

ID=23671557

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT96912861T ATE203907T1 (de)	1995-04-12	1996-04-10	Dermatologische zubereitung zur behandlung von aktinischen keratosen

Country Status (12)

Country	Link
US (2)	US5627187A (de)
EP (1)	EP0822816B1 (de)
AT (1)	ATE203907T1 (de)
AU (1)	AU707853B2 (de)
CA (1)	CA2215840A1 (de)
DE (1)	DE69614375T2 (de)
DK (1)	DK0822816T3 (de)
ES (1)	ES2162051T3 (de)
GR (1)	GR3037031T3 (de)
IL (1)	IL117882A0 (de)
PT (1)	PT822816E (de)
WO (1)	WO1996032112A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6203803B1 (en)	1994-12-14	2001-03-20	Societe L'oreal S.A.	Use of a substance P antagonist in a cosmetic composition, and the composition thus obtained
IL140005A0 (en) *	1998-06-26	2002-02-10	Aventis Pharm Prod Inc	Method of treatment for dermatological disorders and compositions therefor
WO2002020663A2 (en) *	2000-09-06	2002-03-14	Ap Pharma, Inc.	Degradable polyacetal polymers
US6670335B2 (en)	2001-03-05	2003-12-30	A. P. Pharma, Inc.	Fluorouracil-containing formulation
US20030152630A1 (en) *	2001-05-11	2003-08-14	Ng Steven Y.	PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers
US6590059B2 (en)	2001-05-11	2003-07-08	Ap Pharma, Inc.	Bioerodible polyorthoesters from dioxolane-based diketene acetals
US6524606B1 (en) *	2001-11-16	2003-02-25	Ap Pharma, Inc.	Bioerodible polyorthoesters containing amine groups
US8313760B2 (en)	2002-05-24	2012-11-20	Angiotech International Ag	Compositions and methods for coating medical implants
CN101134119A (zh)	2002-05-24	2008-03-05	血管技术国际股份公司	用于涂覆医用植入物的组合物和方法
KR101167579B1 (ko)	2003-04-29	2012-07-27	오렉시젠 세러퓨틱스 인크.	체중감량용 조성물
WO2005007129A2 (en) *	2003-07-17	2005-01-27	Angiotech International Ag	Topical formulations with bioactive components
US20050136015A1 (en) *	2003-12-17	2005-06-23	McKie Derrick B.	Topical use of halosalicylic acid derivatives
PT2135603E (pt)	2005-11-22	2013-04-03	Orexigen Therapeutics Inc	Composições e métodos para aumentar a sensibilidade à insulina
US8916195B2 (en)	2006-06-05	2014-12-23	Orexigen Therapeutics, Inc.	Sustained release formulation of naltrexone
WO2008060964A2 (en)	2006-11-09	2008-05-22	Orexigen Therapeutics, Inc.	Unit dosage package and methods for administering weight loss medications
CA2725930A1 (en)	2008-05-30	2009-12-30	Orexigen Therapeutics, Inc.	Methods for treating visceral fat conditions
EP2143421A1 (de) *	2008-07-07	2010-01-13	Almirall Hermal GmbH	Zusammensetzung zur topischen Behandlung von Strahlenkeratose
ES2762113T3 (es)	2010-01-11	2020-05-22	Nalpropion Pharmaceuticals Inc	Métodos de proporcionar terapia de pérdida de peso en pacientes con depresión mayor
PL4104824T3 (pl)	2012-06-06	2025-11-12	Nalpropion Pharmaceuticals Llc	Kompozycja do zastosowania w sposobie leczenia nadwagi i otyłości u pacjentów z wysokim ryzykiem sercowo-naczyniowym
US8969371B1 (en)	2013-12-06	2015-03-03	Orexigen Therapeutics, Inc.	Compositions and methods for weight loss in at risk patient populations

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2802005A (en) *		1957-08-06		S-eluorourace
US2000213A (en) *	1932-07-18	1935-05-07	Standard Brands Inc	Process for the manufacture of hydroxy carboxylic acids
US2265945A (en) *	1938-04-09	1941-12-09	Du Pont	Organic acid synthesis
US2382889A (en) *	1941-07-22	1945-08-14	Lock Ritchie Hart	Manufacture of lactic acid and salts thereof
US2970084A (en) *	1958-01-21	1961-01-31	Miles Lab	Production of citric acid by fermentation
US3114770A (en) *	1959-01-20	1963-12-17	Orandi & Massera Sa Ind & Com	Recovery of tartaric acid, as the calcium salt, from wine dregs
US2972566A (en) *	1959-12-07	1961-02-21	Kyowa Hakko Kogyo Kk	Process for the production of l-malic acid
US3063910A (en) *	1960-02-03	1962-11-13	Kyowa Hakko Kogyo Kk	Method of producing l-malic acid by fermentation
US3274074A (en) *	1963-10-24	1966-09-20	Kerr Mc Gee Oil Ind Inc	Preparation of salicyclic acid by microbiological oxidation of naphthalene in the presence of a boron compound
US4363815A (en) *	1975-07-23	1982-12-14	Yu Ruey J	Alpha hydroxyacids, alpha ketoacids and their use in treating skin conditions
US4197316A (en) *	1975-07-23	1980-04-08	Scott Eugene J Van	Treatment of dry skin
US4234599A (en) *	1978-10-04	1980-11-18	Scott Eugene J Van	Treatment of skin keratoses with α-hydroxy acids and related compounds
US5008294A (en) *	1985-02-11	1991-04-16	Chemex Pharmaceuticals, Inc.	Methods of treating tumors with compositions of catecholic butanes
US4695590A (en) *	1986-05-05	1987-09-22	California Health Technologies	Method for retarding aging
US5326790A (en) *	1986-11-19	1994-07-05	Dermatologic Research Corporation	Administration of skin medications by use of dicarboxylic acids and derivatives
US5389677B1 (en) *	1986-12-23	1997-07-15	Tristrata Inc	Method of treating wrinkles using glycalic acid
US5091171B2 (en) *	1986-12-23	1997-07-15	Tristrata Inc	Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
US5385938B1 (en) *	1986-12-23	1997-07-15	Tristrata Inc	Method of using glycolic acid for treating wrinkles
US5167649A (en) *	1988-08-22	1992-12-01	Zook Gerald P	Drug delivery system for the removal of dermal lesions
DE69003670T2 (de) *	1989-01-05	1994-01-27	Otsuka Pharma Co Ltd	Nicht einspritzbares karzinostatisches mittel zur vorbeugung der entzündung durch 5-fluoruracil und verfahren zur behandlung von krebs.
US5093360A (en) *	1989-04-07	1992-03-03	Yu Ruey J	Retinal, derivatives and their therapeutic use
US5122514A (en) *	1990-04-23	1992-06-16	Abbott Laboratories	Psoriasis treatment
DE19505328C1 (de) *	1995-02-17	1996-06-20	Boehringer Mannheim Gmbh	Verwendung von Fluoruracil zur Behandlung von Nagelpilz
DE19549330A1 (de) *	1995-02-17	1996-08-22	Boehringer Mannheim Gmbh	Mittel zur Behandlung von Nagelpilz

1995
- 1995-04-12 US US08/421,674 patent/US5627187A/en not_active Expired - Fee Related
1996
- 1996-04-10 WO PCT/US1996/005346 patent/WO1996032112A1/en not_active Ceased
- 1996-04-10 DK DK96912861T patent/DK0822816T3/da active
- 1996-04-10 ES ES96912861T patent/ES2162051T3/es not_active Expired - Lifetime
- 1996-04-10 EP EP96912861A patent/EP0822816B1/de not_active Expired - Lifetime
- 1996-04-10 AU AU55535/96A patent/AU707853B2/en not_active Ceased
- 1996-04-10 CA CA002215840A patent/CA2215840A1/en not_active Abandoned
- 1996-04-10 AT AT96912861T patent/ATE203907T1/de not_active IP Right Cessation
- 1996-04-10 PT PT96912861T patent/PT822816E/pt unknown
- 1996-04-10 DE DE69614375T patent/DE69614375T2/de not_active Expired - Fee Related
- 1996-04-11 IL IL11788296A patent/IL117882A0/xx unknown
1997
- 1997-02-13 US US08/800,255 patent/US5817666A/en not_active Expired - Fee Related
2001
- 2001-10-29 GR GR20010401901T patent/GR3037031T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
IL117882A0 (en)	1996-08-04
DE69614375D1 (de)	2001-09-13
DK0822816T3 (da)	2001-11-12
US5817666A (en)	1998-10-06
DE69614375T2 (de)	2002-05-23
AU5553596A (en)	1996-10-30
MX9707850A (es)	1998-08-30
PT822816E (pt)	2002-01-30
US5627187A (en)	1997-05-06
GR3037031T3 (en)	2002-01-31
AU707853B2 (en)	1999-07-22
ES2162051T3 (es)	2001-12-16
CA2215840A1 (en)	1996-10-17
EP0822816A4 (de)	1998-12-30
EP0822816B1 (de)	2001-08-08
EP0822816A1 (de)	1998-02-11
WO1996032112A1 (en)	1996-10-17

Similar Documents

Publication	Publication Date	Title
DE69614375D1 (de)	2001-09-13	Dermatologische zubereitung zur behandlung von aktinischen keratosen
DE68923819D1 (de)	1995-09-21	Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen.
MX9603520A (es)	1998-01-31	Derivados del acido hidroxamico y acido carboxilico, procesos para su preparacion y su uso.
AU2080988A (en)	1989-01-30	Esters of 13-trans-retinoic acid
ATE195527T1 (de)	2000-09-15	Neue steroidester zur behandlung von hauterkrankungen
ATE230757T1 (de)	2003-01-15	Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten
MA23170A1 (fr)	1994-12-31	Procede de preparation d'un nouveau compose .
ES2114616T5 (es)	2002-07-16	Acidos dicarboxilicos alifaticos insaturados.
NO983864L (no)	1998-08-21	Morfin- og diamorfinsalter av anioniske, ikke-narkotiske analgetika av den substituerte karboksyltypen
EP0850067A4 (de)	1999-12-15	Verfahren zur krebsbehandlung unter verwendung von 6-(3-(1-adamantyl)-4-hydroxyphenyl)2 naphtalincarbonsäure
CA2270558A1 (en)	1998-05-14	Treatment of autoimmune diseases by photochemotherapy
FI925944A0 (fi)	1992-12-30	Arylalkylestrar av 4,5-dihydroxi-9,10-dihydro-9,10-dioxo-2-antracenkarboxylsyra med terapeutisk effekt
TR199801184T2 (xx)	1998-09-21	Analjezik tesirli yeni bile�ikler.
ES2044170T3 (es)	1994-01-01	Sal de estroncio, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen.
ES2006121A6 (es)	1989-04-01	Procedimiento para la preparacion de una composicion farmaceutica destinada al tratamiento de enfermedades cutaneas.
DE69632677D1 (de)	2004-07-15	Verwendung eines Rifamycin-Derivates zur Herstellung eines Medikamentes zur Behandlung von Krankheiten verursacht durch Helicobacter pylori-Infektionen
ATE306278T1 (de)	2005-10-15	Behandlung von knochenleiden mit adrenomedullin
ATE195430T1 (de)	2000-09-15	Niedrig dosierte steroidtabletten, die gallussäureester als antioxidans enthalten, verfahren zur herstellung und die verwendung
NO308195B1 (no)	2000-08-14	Anvendelse av benzydamin til fremstilling av et legemiddel ved behandling av patologiske tilstander forÕrsaket av TNF
DK0808306T3 (da)	2000-03-06	Hidtil ukendte pyridin- eller pyridazinderivater, fremgangsmåder til fremstilling deraf og lægemidler indeholdende disse fo
NO972558L (no)	1997-08-05	Sett for osteoporose-behandlingssyklus
IL115016A0 (en)	1995-12-08	Methods for bone healing and fracture repair
NO952904L (no)	1995-07-21	Lysinsalt av 6-klor-5-fluor-3-(2-tenoyl)-2-oxindol-1-karboksamide
ATA901889A (de)	1994-07-15	Verfahren zur herstellung von wasserlöslichem primycin und seinen komponenten sowie von diese enthaltenden pharmazeutischen präparaten
DE3991360T1 (de)	1991-01-10	Verfahren zur herstellung von wasserloeslichem primycin und seinen komponenten sowie von diese enthaltenden pharmazeutischen praeparaten

Legal Events

Date	Code	Title	Description
2002-01-15	UEP	Publication of translation of european patent specification
2004-01-15	REN	Ceased due to non-payment of the annual fee